PROVECTUS BIOPHARMACEUTICA Profile

Performance

   

Odds of Distress

88%88%
Check how we calculate scores
Equity ratings for PROVECTUS BIOPHARMACEUTICALS IN are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting June 24, 2019 and ending today September 22, 2019. Click here to learn more.

PROVECTUS BIOPHARMACEUTICA Summary

PROVECTUS BIOPHARMACEUTICALS IN [PVCT] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Micro-Cap' category with current market capitalization of 26.36M. PROVECTUS BIOPHARMACEUTICA conducts business under Healthcare sector and is part of Drug Manufacturers - Specialty & Generic industry. The entity has 387.59M outstanding shares of which 1.82M shares are at this time shorted by private and institutional investors with about 0.47 trading days to cover. PROVECTUS PHARMA currently holds about 1.32M in cash with (5.29M) of positive cash flow from operations.
Check PROVECTUS BIOPHARMACEUTICA Probability Of Bankruptcy

Ownership Allocation (%)

PROVECTUS BIOPHARMACEUTICA Target Price Odds Analysis

Odds Below 0.068HorizonTargetOdds Above 0.068
62.42%30 days 0.07 37.37%
Based on normal probability distribution, the odds of PROVECTUS BIOPHARMACEUTICA to move above current price in 30 days from now is about 37.37% (This PROVECTUS BIOPHARMACEUTICALS IN probability density function shows the probability of PROVECTUS BIOPHARMACEUTICA OTC Stock to fall within a particular range of prices over 30 days) .

PROVECTUS BIOPHARMACEUTICA Risk Profiles

PROVECTUS BIOPHARMACEUTICA Key Fundamentals

PROVECTUS BIOPHARMACEUTICA Against Markets

PROVECTUS BIOPHARMACEUTICA Vital Trading Data

Provectus Biopharmaceuticals, Inc., a biopharmaceutical company, engages in developing drugs based on halogenated xanthenes for oncology and dermatology indications. Provectus Biopharmaceuticals, Inc. was founded in 2002 and is based in Knoxville, Tennessee. PROVECTUS BIOPHARMACEUTICA operates under Drug Manufacturers - Specialty Generic classification in USA and is traded on BATS Exchange. It employs 2 people. more
NamePROVECTUS BIOPHARMACEUTICALS IN
Chairman of the BoardEdward PershingView All
Macroaxis Advice
InstrumentUSA OTC Stock View All
Business Address10025 Investment Drive
ExchangeBATS Exchange
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
BenchmarkDOW
Websitewww.provectusbio.com
Phone866 594 5999
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2020
Most Recent QuarterJune 30, 2019
Last Fiscal Year EndDecember 31, 2018
Date Short InterestSeptember 30, 2016

PROVECTUS BIOPHARMACEUTICA Corporate Directors

Alfred Smith Independent Director
Bruce Horowitz Director
Jan Koe Independent Director
Additionally take a look at Your Equity Center. Please also try Commodity Channel Index module to use commodity channel index to analyze current equity momentum.
Search macroaxis.com